We’re building the future of cellular analysis
Oncoptic is a deep-tech medical technology company developing a next-generation platform for advanced disease detection and cellular analysis.
Our story
The primary goal of Oncoptic is to transform how complex diseases — including blood cancer and other cellular-level disorders — are detected, monitored, and understood.
By focusing on individual cell analysis, we provide deeper biological insights beyond traditional diagnostic approaches, enabling more precise and personalized healthcare solutions.
To extract meaningful biological information from individual cells — supporting faster, more accurate diagnostics and the future of personalized medicine.
A new generation of medical analysis platforms that move healthcare toward a more precise, data-driven, and personalized approach to Leukemia and other complex diseases.
What drives us
Precision
We pursue insight at the resolution of a single cell.
Scientific rigor
Every claim is grounded in evidence.
Patient impact
We measure success by lives changed.